Roots Analysis has conducted an in-depth research on women’s digital health solutions, analyzing the market landscape and capital raised, presenting lucrative opportunities for investors.
Key Market Insights
§ Introduction of digital health solutions to improve efficiency and quality of basic healthcare needs have enabled the establishment of a more proactive approach to deal with the concerns related to women’s health
§ A detailed analysis of the women's digital health funding and women's digital health investment activity that has taken place, since 2011.[GK1]
§ Currently, more than 180 companies are actively engaged in the development of women’s digital health solutions; over 50% of such players have been established post-2016
§ Based on our proprietary company health indexing approach, we awarded an overall company strength score, ranging between 26 to 69, to the innovator companies involved in the field of women’s digital health
§ A series of notable value propositions are being offered by players associated with women’s digital health domain; more than 60% of these players offer product customizability to the customers
§ In pursuit of building a competitive edge, stakeholders are actively upgrading their existing capabilities and enhancing their respective product offerings to comply with the evolving industry benchmarks
§ Having realized the opportunity associated with this lucrative segment, several investors have collectively invested a sum of ~USD 3.4 billion, since 2012
§ Nearly 90% of the capital invested in the companies has, so far, come in from venture capital funding; some companies have already gone public
§ Since 2012, investments worth over USD 150 million have been made in the form of seed funding; this reflects the growing belief of investors in the women’s digital health solutions
§ In 2021, a notable growth was observed in the business assets of Company A; the number of shares increased exponentially in the same year, reaching a total of ~15 million
§ Considering the fundamental trends associated with Company A over the past three years, we observed that the company’s liquidity position reached at its peak in the year 2021; specifically, the current ratio stands at 13.11
§ Based on the 10-Day moving average, the price of Company A’s security has demonstrated an upward trend since mid December 2022, offering several buying opportunities
§ Given the rise in the adoption of digital solutions among women, the women’s digital health market is anticipated to grow at an annualized rate of nearly 20% over the next decade
§ Using our proprietary approach, based on strength and qualitative understanding of the value offered, we shortlisted 58 companies as potential acquisition targets for investors seeking to tap into the opportunity in this domain
§ It is imperative that public ventures in the women’s digital health domain adopt varying strategies and continually monitor both internal and external risk parameters, in order to detect anomalies as early as possible
§ Company A has managed to capture the attention of a large number of investors, resulting in a consistent influx of capital and has provided steady returns to its investors in a short period of time
Table of Contents
Excel Deliverables
1. Innovators and Product Dataset
1.1. Analysis Notes
1.2. Innovator Landscape
1.3. Product Landscape
1.4. Value Proposition
1.5. Key Acquisition Targets
1.6. AI – AVII Appendices
2. FUNDING AND INVESTMENT ANALYSIS
2.1. Analysis Notes
2.2. Summary Dashboard
2.3. Capital Investments in Women’s Digital Health
2.4 AI – AIV Appendices
3. FUNDAMENTAL AND TECHNICAL FINANCIAL ANALYSIS
The information presented in this analysis is spread across separate MS Excel sheets, which provide information on key financial parameters and competitive insights based on historical and prevalent trends.
4. MARKET FORECAST AND OPPORTUNITY ANALYSIS
4.1. Analysis Notes
4.2. Market Forecast and Opportunity Analysis: Summary
4.3. Market Forecast and Opportunity Analysis: Marketed Products Dataset
4.4. Market Forecast and Opportunity Analysis: Pricing Dataset
4.5. Market Forecast and Opportunity Analysis: Applications / Software (Conservative Scenario)
4.6. Market Forecast and Opportunity Analysis: Applications / Software (Base Scenario)
4.7. Market Forecast and Opportunity Analysis: Applications / Software (Optimistic Scenario)
4.8. Market Forecast and Opportunity Analysis: Devices (Conservative Scenario)
4.9. Market Forecast and Opportunity Analysis: Devices (Base Scenario)
4.10. Market Forecast and Opportunity Analysis: Devices (Optimistic Scenario)
4.11. Market Forecast and Opportunity Analysis: Services (Conservative Scenario)
4.12. Market Forecast and Opportunity Analysis: Services (Base Scenario)
4.13. Market Forecast and Opportunity Analysis: Services (Optimistic Scenario)
4.14. Market Forecast and Opportunity Analysis: Prevalence
4.15. Market Forecast and Opportunity Analysis: Validation
4.16. Market Forecast and Opportunity Analysis: Population Data
4.17. Market Forecast and Opportunity Analysis: UN World Population Data
5. RETURN ON INVESTMENTS
5.1. Analysis Notes
5.2. Estimated RoI for Investors in Company A
PowerPoint Deliverable
1. CONTEXT
2. PROJECT OBJECTIVES
3. PROJECT APPROACH
4. EXECUTIVE SUMMARY
Section I: Introduction to Women’s Digital Health Solutions and Innovator Landscape
5. THE WOMEN’S DIGITAL HEALTH MARKET
5.1. Overview
5.2. Importance of FemTech Industry
5.3. Digital Solutions focused on Women’s Health
5.4. Leading Products and Challenges
5.5. Case Study: Business Success
5.6. Case Study: Business Decline
6. WOMEN’S DIGITAL HEALTH: INNOVATOR LANDSCAPE
6.1. Methodology
6.2. Innovators in the Women’s Digital Health Market
6.3. Analysis of Innovator Landscape
6.4. Concluding Remarks
7. WOMEN’S DIGITAL HEALTH: PRODUCT LANDSCAPE AND COMPANY HEALTH INDEXING
7.1. List of Products: Information on Current Status of Development and Type of Product(s) / Solution(s)
7.2. Analysis of Product Landscape: Distribution by Current Status of Development and Type of Product(s) / Solution(s)
7.3. List of Products: Information on Regulatory Approval(s) and Therapeutic Application Area(s)
7.4. Analysis of Product Landscape: Distribution by Regulatory Approval(s) and Therapeutic Application Area(s)
7.5. List of Products: Information on Usage Period with respect to Pregnancy, Purpose(s) and End User(s)
7.6. Analysis of Product Landscape: Distribution by Usage Period with respect to Pregnancy, Purpose(s) and End User(s)
7.7. Company Health Indexing Methodology
7.8. Company Health Indexing Scoring
7.9. Company Health Indexing
8. VALUE PROPOSITION ANALYSIS
8.1. Overview and Methodology
8.2. Product-related Value
8.3. Value to Patients
8.4. Developer Value
8.5. Outreach-related Value
8.6. Concluding Remarks
9. COMPANY COMPETITIVENESS ANALYSIS
9.1. Overview and Methodology
9.2. Women’s Digital Health Solution Developers: Company Competitiveness Analysis
Section II: Analysis of Investments
10. FUNDING AND INVESTMENT ANALYSIS
10.1. Overview
10.2. Analysis by Type of Funding
10.3. Analysis by Geography
10.4. Most Active Players and Popular Investors
10.5. Trends Across Various Funding Categories
10.6. Summary of Funding and Investments
Section III: Financial Analysis of Key Public Ventures
11. FINANCIAL ANALYSIS OF PUBLIC VENTURES
11.1. Fundamental Financial Analysis Overview
11.1.1. Financial Ratios (Interpretation Guide): Liquidity Ratios
11.1.2. Financial Ratios (Interpretation Guide): Financial and Business Risk Ratios
11.1.3. Financial Ratios (Interpretation Guide): Turnover / Efficiency Ratios
11.1.4. Financial Ratios (Interpretation Guide): Profitability Ratios
11.1.5. Financial Ratios (Interpretation Guide): Market Value Ratios
11.1.6. Financial Ratios (Interpretation Guide): Stability Ratios
11.1.7. Case Study 1
11.1.8. Case Study 2
11.1.9. Case Study 3
11.2. Technical Financial Analysis Overview
11.2.1. Technical Indicators (Interpretation Guide): Candlestick Charts
11.2.2. Technical Indicators (Interpretation Guide): Moving Averages
11.2.3. Technical Indicators (Interpretation Guide): Bollinger Band®
11.2.4. Technical Indicators (Interpretation Guide): Relative Strength Index
11.2.5. Technical Indicators (Interpretation Guide): William’s R Analysis
11.2.6. Technical Indicators (Interpretation Guide): Moving Average Convergence Divergence
11.2.7. Case Study 1
11.2.8. Case Study 2
11.2.9. Case Study 3
12. COMPANY PROFILES OF PUBLIC VENTURES
12.1. Bonzun
12.1.1. Key Highlights
12.1.1.1. Company Overview
12.1.1.2. Key Executives
12.1.1.3. Insights from Balance Sheet
12.1.1.4. Product / Service Portfolio
12.1.1.5. Recent Developments
12.1.2. Key Financial Details
12.1.2.1. Company Investments
12.1.2.2. Company Fundamentals
12.1.2.3. Company Technicals
12.2. HeraMED
12.2.1. Key Highlights
12.2.1.1. Company Overview
12.2.1.2. Key Executives
12.2.1.3. Insights from Balance Sheet
12.2.1.4. Product / Service Portfolio
12.2.1.5. Recent Developments
12.2.2. Key Financial Details
12.2.2.1. Company Investments
12.2.2.2. Company Fundamentals
12.2.2.3. Company Technicals
12.3. Sera Prognostics
12.3.1. Key Highlights
12.3.1.1. Company Overview
12.3.1.2. Key Executives
12.3.1.3. Insights from Balance Sheet
12.3.1.4. Product / Service Portfolio
12.3.1.5. Recent Developments
12.3.2. Key Financial Details
12.3.2.1. Company Investments
12.3.2.2. Company Fundamentals
12.3.2.3. Company Technicals
Section IV: Market Forecast and Opportunity Analysis
13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Overview and Methodology
13.2. Global Women’s Digital Health Market, 2023-2035
13.3. Distribution Across Key Market Segments
13.3.1. Women’s Digital Health Market: Distribution by Type of Solution, 2023 and 2035
13.3.1.1. Women’s Digital Health Market for Applications / Software, 2023-2035
13.3.1.2. Women’s Digital Health Market for Devices, 2023-2035
13.3.1.3. Women’s Digital Health Market for Services, 2023-2035
13.3.2. Women’s Digital Health Market: Distribution by Therapeutic Application Area, 2023 and 2035
13.3.2.1. Women’s Digital Health Market for Fetal Health, 2023-2035
13.3.2.2. Women’s Digital Health Market for General Wellness, 2023-2035
13.3.2.3. Women’s Digital Health Market for Menstrual Cycle, 2023-2035
13.3.2.4. Women’s Digital Health Market for Pelvic Care, 2023-2035
13.3.2.5. Women’s Digital Health Market for Reproductive Health / Fertility, 2023-2035
13.3.3. Women’s Digital Health Market: Distribution by Key Geographical Regions, 2023 and 2035
13.3.3.1. Women’s Digital Health Market in North America, 2023-2035
13.3.3.2. Women’s Digital Health Market in Europe, 2023-2035
13.3.3.3. Women’s Digital Health Market in Asia-Pacific, 2023-2035
13.3.3.4. Women’s Digital Health Market in Middle East and North Africa, 2023-2035
13.3.3.5. Women’s Digital Health Market in Latin America, 2023-2035
13.4. Women’s Digital Health Market for Applications / Software, 2023-2035
13.4.1. Women’s Digital Health Market for Applications / Software: Distribution by Therapeutic Application Area, 2023 and 2035
13.4.1.1. Women’s Digital Health Applications / Software Market for Fetal Health, 2023-2035
13.4.1.2. Women’s Digital Health Applications / Software Market for General Wellness, 2023-2035
13.4.1.3. Women’s Digital Health Applications / Software Market for Menstrual Cycle, 2023-2035
13.4.1.4. Women’s Digital Health Applications / Software Market for Pelvic Care, 2023-2035
13.4.1.5. Women’s Digital Health Applications / Software Market for Reproductive Health / Fertility, 2023-2035
13.4.2. Women’s Digital Health Market for Applications / Software: Distribution by Key Geographical Regions, 2023 and 2035
13.4.2.1. Women’s Digital Health Applications / Software Market in North America, 2023-2035
13.4.2.2. Women’s Digital Health Applications / Software Market in Europe, 2023-2035
13.4.2.3. Women’s Digital Health Applications / Software Market in Asia-Pacific, 2023-2035
13.4.2.4. Women’s Digital Health Applications / Software Market in Middle East and North Africa, 2023-2035
13.4.2.5. Women’s Digital Health Applications / Software Market in Latin America, 2023-2035
13.5. Women’s Digital Health Market for Devices, 2023-2035
13.5.1. Women’s Digital Health Market for Devices: Distribution by Therapeutic Application Area, 2023 and 2035
13.5.1.1. Women’s Digital Health Devices Market for Fetal Health, 2023-2035
13.5.1.2. Women’s Digital Health Devices Market for General Wellness, 2023-2035
13.5.1.3. Women’s Digital Health Devices Market for Menstrual Cycle, 2023-2035
13.5.1.4. Women’s Digital Health Devices Market for Pelvic Care, 2023-2035
13.5.1.5. Women’s Digital Health Devices Market for Reproductive Health / Fertility, 2023-2035
13.5.2. Women’s Digital Health Market for Devices: Distribution by Key Geographical Regions, 2023 and 2035
13.5.2.1. Women’s Digital Health Devices Market in North America, 2023-2035
13.5.2.2. Women’s Digital Health Devices Market in Europe, 2023-2035
13.5.2.3. Women’s Digital Health Devices Market in Asia-Pacific, 2023-2035
13.5.2.4. Women’s Digital Health Devices Market in Middle East and North Africa, 2023-2035
13.5.2.5. Women’s Digital Health Devices Market in Latin America, 2023-2035
13.6. Women’s Digital Health Market for Services, 2023-2035
13.6.1. Women’s Digital Health Market for Services: Distribution by Therapeutic Application Area, 2023 and 2035
13.6.1.1. Women’s Digital Health Services Market for Fetal Health, 2023-2035
13.6.1.2. Women’s Digital Health Services Market for General Wellness, 2023-2035
13.6.1.3. Women’s Digital Health Services Market for Menstrual Cycle, 2023-2035
13.6.1.4. Women’s Digital Health Services Market for Pelvic Care, 2023-2035
13.6.1.5. Women’s Digital Health Services Market for Reproductive Health / Fertility, 2023-2035
13.6.2. Women’s Digital Health Market for Services: Distribution by Key Geographical Regions, 2023 and 2035
13.6.2.1. Women’s Digital Health Services Market in North America, 2023-2035
13.6.2.2. Women’s Digital Health Services Market in Europe, 2023-2035
13.6.2.3. Women’s Digital Health Services Market in Asia-Pacific, 2023-2035
13.6.2.4. Women’s Digital Health Services Market in Middle East and North Africa, 2023-2035
13.6.2.5. Women’s Digital Health Services Market in Latin America, 2023-2035
Section V: Key Acquisition Targets, Business Risk Assessment and Return on Investments
14. KEY ACQUISITION TARGETS
14.1. Overview and Methodology
14.2. Key Acquisition Targets
15. BUSINESS RISK ASSESSMENT
15.1. Chapter Overview
15.2. Operations-related Risks
15.3. Product / Technology Risks
15.4. Business-related Risks
15.5. Financial / Asset-related Risks
15.6. Other Risks
16. RETURN ON INVESTMENTS
16.1. Overview and Methodology
16.2. Case Study
17. CONCLUSION
18. APPENDICES
Get more details on the report https://www.rootsanalysis.com/reports/opportunities-in-women-digital--health-market.html
You may also be interested in the following titles:
Quantum Computing in Drug Discovery Services Market
You may also like to learn what our experts are sharing in Roots educational series:
Monkeypox: Disease Overview, Transmission and Diagnosis
Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic?
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Comments